Particle Therapy Market Global Industry Analysis, Value, Share, Growth, Trends, and Forecast 2018 - 2026

Based on therapy, the market has been segmented into proton therapy, carbon therapy, and other therapy. The therapy segment has been analyzed based on available centers providing particle therapy, cost-effectiveness, and preference for therapy by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on services, the market has been segmented into cyclotrons, synchrotrons, and synchrocyclotrons. The therapy segment has been analyzed based on available centers established with different services in different regions/country, cost-effectiveness, and preference for therapy by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on end-user, the particle therapy market has been classified into hospitals, specialty clinics, ambulatory surgical centers, and others. The particle therapy market has also been segmented based on the application of particle therapy for cancer treatment. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of region, the global particle therapy market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global particle therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Varian Medical Systems, Inc., Hitachi, Ltd., IBA Worldwide, Sumitomo Heavy Industries, Ltd., Advanced Oncotherapy PLC., Mevion Medical Systems, Inc., Provision Healthcare, LLC,  Optivus Proton Therapy, Inc., Protom International, Inc., and Danfysik A/S.

The global particle therapy market has been segmented as given below:

Global Particle Therapy Market, by Therapy
Proton Therapy
Carbon Therapy
Other Therapy

Global Particle Therapy Market, by Cancer Application
Pediatric Cancer
Lung Cancer
Bladder Cancer
Brain and Spinal Cord Tumors (BSCT)
Breast Cancer
Gastrointestinal (GI) Cancers
Hepatocellular Carcinoma (HCC)
Head and Neck Cancers (HNC)
Others

Global Particle Therapy Market, by Services
Cyclotrons
Synchrotrons
Synchrocyclotrons

Global Particle Therapy Market, by End-user
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others

Global Particle Therapy Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC countries
South Africa
Rest of Middle East & Africa

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.